Perrigo (PRGO)
(Delayed Data from NYSE)
$27.69 USD
-0.49 (-1.74%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $27.72 +0.03 (0.11%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth C Momentum B VGM
- YR Estimate
- 12/31/2023
- 12/31/2022
- 12/31/2021
- 12/31/2020
- 12/31/2019
- Revenue - Line of Business (LOBR)
- Net Sales: Consumer Self-Care Americas (CSCA)
- 2,962.30
- 2,925.90
- 2,693.10
- 2,693.00
- 2,487.70
- Revenue - Line of Business (LOBR)
- Net Sales: Consumer Self-Care International (CSCI)
- 1,693.30
- 1,525.70
- 1,445.60
- 1,395.20
- 1,382.20
- Revenue - Line of Business (LOBR)
- Net Sales: CSCA: Nutrition
- 563.20
- 520.40
- 401.90
- 388.30
- 395.30
- Revenue - Line of Business (LOBR)
- Net Sales: CSCA: Upper Respiratory
- 559.20
- 564.60
- 483.10
- 505.80
- 529.30
- Revenue - Line of Business (LOBR)
- Net Sales: CSCA: Digestive Health
- 505.30
- 495.50
- 475.10
- 471.30
- 429.20
- Revenue - Line of Business (LOBR)
- Net Sales: CSCA: Pain & Sleep-aids
- 396.40
- 412.20
- 405.40
- 434.50
- 390.90
- Revenue - Line of Business (LOBR)
- Net Sales: CSCA: Healthy Lifestyle
- 311.70
- 288.90
- 295.00
- 350.30
- 356.10
- Revenue - Line of Business (LOBR)
- Net Sales: CSCA: Oral care
- 313.90
- 312.90
- 311.90
- 288.20
- 111.70
- Revenue - Line of Business (LOBR)
- Net Sales: CSCA: Skincare
- 196.20
- 187.80
- 183.70
- 167.40
- 191.30
- Revenue - Line of Business (LOBR)
- Net Sales: CSCA: Women's Health
- 46.90
- 45.20
- 38.20
- --
- --
- Revenue - Line of Business (LOBR)
- Net Sales: CSCI: Skincare
- 372.50
- 432.20
- 378.30
- 302.10
- 371.60
- Revenue - Line of Business (LOBR)
- Net Sales: CSCI: Women's Health
- 119.70
- 96.10
- 54.50
- --
- --
- Revenue - Line of Business (LOBR)
- Net Sales: CSCI: Digestive Health
- 41.00
- 21.50
- 25.60
- 26.50
- 27.10
- Revenue - Line of Business (LOBR)
- Net Sales: CSCI: Oral care
- 101.50
- 88.60
- 94.00
- 97.80
- 51.20
- Revenue - Line of Business (LOBR)
- Net Sales: CSCI: Upper Respiratory
- 299.10
- 258.80
- 219.40
- 255.10
- 276.80
- Revenue - Line of Business (LOBR)
- Net Sales: CSCI: Pain & Sleep-aids
- 222.90
- 183.00
- 184.80
- 190.40
- 167.90
- Revenue - Line of Business (LOBR)
- Net Sales: CSCA: VMS (Vitamins, Minerals & Supplements)
- 17.50
- 27.90
- 31.70
- 27.00
- 28.60
- Revenue - Line of Business (LOBR)
- Net Sales: CSCI: VMS (Vitamins, Minerals & Supplements)
- 185.50
- 191.80
- 225.80
- 201.00
- 180.20
- Revenue - Line of Business (LOBR)
- Net Sales: CSCI: Healthy Lifestyle
- 225.70
- 136.40
- 173.30
- 160.20
- 173.80
- Revenue - Geographic (GEOR)
- Geographic Revenue: U.S.
- 2,916.80
- 2,870.00
- 2,565.90
- 2,579.00
- 2,360.30
- Revenue - Geographic (GEOR)
- Geographic Revenue: Europe
- 1,622.50
- 1,474.30
- 1,393.00
- 1,350.60
- 1,335.80
- Revenue - Geographic (GEOR)
- Geographic Revenue: All other countries
- 116.30
- 107.30
- 179.80
- 158.60
- 173.80
- Income - Line of Business (LOBI)
- Gross Profit: Consumer Self-Care Americas: Adjusted (CSCA)
- 926.10
- 826.20
- 793.30
- 880.30
- 829.70
- Income - Line of Business (LOBI)
- Gross Profit: Consumer Self-Care International: Adjusted (CSCI)
- 882.50
- 787.20
- 718.90
- 709.50
- 725.40